Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.2 CHF | +0.48% | -2.40% | -0.75% |
10:09am | DOCMORRIS : Sell rating from UBS | ZD |
04-23 | DOCMORRIS : Deutsche Bank remains its Buy rating | ZD |
Sales 2024 * | 1.18B 1.3B 1.77B | Sales 2025 * | 1.59B 1.75B 2.38B | Capitalization | 914M 1.01B 1.37B |
---|---|---|---|---|---|
Net income 2024 * | -82M -90.41M -123M | Net income 2025 * | -22M -24.26M -33.04M | EV / Sales 2024 * | 0.99 x |
Net Debt 2024 * | 251M 277M 378M | Net Debt 2025 * | 282M 311M 424M | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
-10.9
x | P/E ratio 2025 * |
-42.8
x | Employees | 1,453 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.2% |
Latest transcript on DocMorris AG
1 day | +0.10% | ||
1 week | -2.40% | ||
Current month | -10.79% | ||
1 month | -16.77% | ||
3 months | -21.54% | ||
6 months | +49.69% | ||
Current year | -0.75% |
Managers | Title | Age | Since |
---|---|---|---|
Walter Hess
CEO | Chief Executive Officer | 59 | 14-12-31 |
Founder | 66 | 93-04-05 | |
Marcel Ziwica
DFI | Director of Finance/CFO | 49 | 00-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 10-03-31 | |
Florian Seubert
BRD | Director/Board Member | 51 | 19-05-22 |
Founder | 66 | 93-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 746 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +4.26% | - | |
0.00% | 25 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 73.2 | +0.48% | 55 138 |
24-05-15 | 72.85 | +0.21% | 73,008 |
24-05-14 | 72.7 | -0.55% | 124,141 |
24-05-13 | 73.1 | -1.95% | 125,410 |
24-05-10 | 74.55 | -0.60% | 112,840 |
Delayed Quote Swiss Exchange, May 16, 2024 at 11:30 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.75% | 1.01B | |
-29.72% | 15.43B | |
-20.84% | 12.31B | |
-24.53% | 6.59B | |
+12.34% | 6.3B | |
-8.87% | 5.88B | |
-1.17% | 4.74B | |
+60.03% | 4.7B | |
-5.50% | 4.03B | |
-8.59% | 3.58B |
- Stock Market
- Equities
- ROSE Stock